Wyatt Technology Announces Executive Team Changes
Geofrey Wyatt has been named CEO and Clifford Wyatt named president of Wyatt Technology.
Wyatt Technology, a developer of instrumentation for absolute macromolecular and nanoparticle characterization, announced changes to its executive team on May 1, 2018.
Geofrey Wyatt was named chief executive office, and Clifford Wyatt was named president. Philip Wyatt, who founded the company almost 40 years ago, will become chairman of the board and take on a more passive role, the company reported in a press statement.
The company also announced that Michelle Chen was promoted to vice-president of analytical services and will join the executive team.
Source: Wyatt Technology
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
